JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Higgins, D. L.
Right arrow Articles by Shafer, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Higgins, D. L.
Right arrow Articles by Shafer, J. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 258, Issue 15, 9276-9282, 08, 1983

Steady state kinetic parameters for the thrombin-catalyzed conversion of human fibrinogen to fibrin

DL Higgins, SD Lewis and JA Shafer

Steady state kinetic parameters were evaluated for the hydrolytic release of fibrinopeptides A and B (FPA and FPB) from human fibrinogen by human thrombin at pH 7.4, 37 degrees C, and gamma/2 0.15. At low concentrations of fibrinogen (less than 0.4 microM), the release of FPA from A alpha-chains was first order with respect to both the concentration of fibrinogen A alpha-chains and thrombin. The second order rate constant yielded a value of 11.6 (+/- 0.3) X 10(6) M-1 S-1 for the specificity constant (kcat/Km) for this process. Values of 84 (+/- 4) S-1 and 7.2 (+/- 0.9) microM were evaluated for kcat and Km for the thrombin-catalyzed release of FPA from normal human fibrinogen. The amino acid replacement ArgA alpha 16 leads to His present in fibrinogen Petoskey was shown to result in a 160-fold decrease in the specificity constant for hydrolysis at A alpha 16 and concomitant release of FPA. A kinetic analysis for determination of the sequentiality of release of fibrinopeptides was presented. It indicated that at least 97% of FPB was released after FPA. The specificity constant for release of FPB from intact fibrinogen (if it occurs) was less than 3% of that for release of FPA and less than 10% of that for release of FPB from des-A fibrinogen. The specificity constant for the release of FPB from des-A fibrinogen was 4.2 (+/- 0.2) X 10(6) M-1 S-1. The polymerization inhibitors EDTA and Gly-Pro-Arg-Pro inhibited release of FPB but not FPA. These observations are consistent with the generally accepted view that the predominant pathway for the conversion of normal human fibrinogen to fibrin is one wherein FPA is released, des-A fibrinogen polymerizes, and then FPB is released.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
T. Myles and L. L. K. Leung
Thrombin Hydrolysis of Human Osteopontin Is Dependent on Thrombin Anion-binding Exosites
J. Biol. Chem., June 27, 2008; 283(26): 17789 - 17796.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
Y. Banerjee, R. Lakshminarayanan, S. Vivekanandan, G. S. Anand, S. Valiyaveettil, and R. M. Kini
Biophysical Characterization of Anticoagulant Hemextin AB Complex from the Venom of Snake Hemachatus haemachatus
Biophys. J., December 1, 2007; 93(11): 3963 - 3976.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. A. Amelot, M. Tagzirt, G. Ducouret, R. L. Kuen, and B. F. Le Bonniec
Platelet Factor 4 (CXCL4) Seals Blood Clots by Altering the Structure of Fibrin
J. Biol. Chem., January 5, 2007; 282(1): 710 - 720.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. E. Adams and J. A. Huntington
Thrombin-Cofactor Interactions: Structural Insights Into Regulatory Mechanisms
Arterioscler. Thromb. Vasc. Biol., August 1, 2006; 26(8): 1738 - 1745.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Panizzi, R. Friedrich, P. Fuentes-Prior, K. Richter, P. E. Bock, and W. Bode
Fibrinogen Substrate Recognition by Staphylocoagulase{middle dot}(Pro)thrombin Complexes
J. Biol. Chem., January 13, 2006; 281(2): 1179 - 1187.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. L. Moen, O. V. Gorkun, J. W. Weisel, and S. T. Lord
Recombinant B{beta}Arg14His fibrinogen implies participation of N-terminus of B{beta} chain in desA fibrin polymerization
Blood, October 1, 2003; 102(7): 2466 - 2471.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. E. Brummel, S. G. Paradis, S. Butenas, and K. G. Mann
Thrombin functions during tissue factor-induced blood coagulation
Blood, June 17, 2002; 100(1): 148 - 152.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
S. T. LORD and O. V. GORKUN
Insight from Studies with Recombinant Fibrinogens
Ann. N.Y. Acad. Sci., June 1, 2001; 936(1): 101 - 116.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. E. Brummel, S. Butenas, and K. G. Mann
An Integrated Study of Fibrinogen during Blood Coagulation
J. Biol. Chem., August 6, 1999; 274(32): 22862 - 22870.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Okumura, O. V. Gorkun, and S. T. Lord
Severely Impaired Polymerization of Recombinant Fibrinogen gamma -364 Asp right-arrow His, the Substitution Discovered in a Heterozygous Individual
J. Biol. Chem., November 21, 1997; 272(47): 29596 - 29601.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. J. Hogg, C. M. Jackson, J. K. Labanowski, and P. E. Bock
Binding of Fibrin Monomer and Heparin to Thrombin in a Ternary Complex Alters the Environment of the Thrombin Catalytic Site, Reduces Affinity for Hirudin, and Inhibits Cleavage of Fibrinogen
J. Biol. Chem., October 18, 1996; 271(42): 26088 - 26095.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. A. Meh, K. R. Siebenlist, and M. W. Mosesson
Identification and Characterization of the Thrombin Binding Sites on Fibrin
J. Biol. Chem., September 20, 1996; 271(38): 23121 - 23125.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Li, D. Galanakis, and D. A. Gabriel
Transient Intermediates in the Thrombin Activation of Fibrinogen
J. Biol. Chem., May 17, 1996; 271(20): 11767 - 11771.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Noeske-Jungblut, B. Haendler, P. Donner, A. Alagon, L. Possani, and W.-D. Schleuning
Triabin, a Highly Potent Exosite Inhibitor of Thrombin
J. Biol. Chem., December 1, 1995; 270(48): 28629 - 28634.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. L. Hall and P. L. Darke
Activation of the Herpes Simplex Virus Type 1 Protease
J. Biol. Chem., September 29, 1995; 270(39): 22697 - 22700.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. L. Mullin, O. V. Gorkun, C. G. Binnie, and S. T. Lord
Recombinant Fibrinogen Studies Reveal That Thrombin Specificity Dictates Order of Fibrinopeptide Release
J. Biol. Chem., August 11, 2000; 275(33): 25239 - 25246.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1983 by the American Society for Biochemistry and Molecular Biology.